Vidac Pharma Holding Plc (ETR:T9G)
0.2150
+0.0100 (4.88%)
At close: Nov 17, 2026
Vidac Pharma Holding Market Cap
Vidac Pharma Holding has a market cap or net worth of €11.1 million as of November 18, 2026. It is the 40,294th most valuable company in the world and the 535th biggest in Germany.
Market Cap
11.10M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#535 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2025, Vidac Pharma Holding's market cap has decreased from 26.85M to 11.10M, a decrease of -58.65%. That is a compound annual growth rate of -61.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 11.10M | -59.89% |
| Dec 30, 2025 | 27.67M | 3.08% |
| Dec 15, 2025 | 26.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| Novogenia AG | 72.60M |
| 2invest AG | 38.15M |
| Biomark Diagnostics | 25.98M |
| Chosa Oncology AB | 3.02M |
| Paion AG | 328.15K |
| bioXXmed AG | 254.19K |
| co.don AG | 133.62K |